Torrent Pharmaceuticals Limited has informed the Exchange about Transcript
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has informed the stock exchanges that the transcript of its conference call with analysts and investors, held to discuss financial results for the quarter ended 30th June 2025 (Q1 FY26), has been uploaded to the company's website. This is a routine regulatory disclosure under SEBI listing rules, following up on the company's earlier communication dated 21-July-2025. The actual transcript content is hosted on Torrent Pharma's investor page as a PDF document. The filing was signed by Company Secretary Chintan M. Trivedi on 31st July 2025.
This is a standard procedural filing with no direct material impact on the stock. Investors who want detailed management commentary on Q1 FY26 performance, outlook, margins, or strategy should review the transcript PDF linked in the filing for any forward-looking cues.